Published in Int J Biol Markers on October 08, 2012
Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer. Ann Lab Med (2016) 0.82
M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients. J Ovarian Res (2015) 0.81
Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus. Mol Ther Methods Clin Dev (2016) 0.77
Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis. Mediators Inflamm (2016) 0.76
Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review. PLoS One (2016) 0.76
The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study. J Cancer (2017) 0.75
Primary aldosteronism in hypertensive patients: clinical implications and target therapy. Eur J Clin Invest (2014) 1.99
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Breast Cancer Res Treat (2008) 1.82
Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care (2010) 1.55
Total thyroidectomy for the treatment of thyroid diseases in an endemic area. South Med J (2006) 1.46
Self-locking first stitch in suture reinforcement of the laparoscopic gastric sleeve. Obes Surg (2013) 1.20
Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. Invest New Drugs (2004) 1.14
Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer (2009) 1.11
Unusual site of recurrent musculoskeletal hydatid cyst: case report and brief review of the literature. World J Gastroenterol (2006) 1.09
EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells. Int J Biochem Cell Biol (2012) 1.05
Laparoscopic ventral hernia repair: pros and cons compared with open hernia repair. JSLS (2008) 1.05
Application of the pedicled anterolateral thigh flap to defects from the pelvis to the knee. Microsurgery (2006) 1.04
Incisional hernioplasty with extraperitoneal onlay polyester mesh. Am Surg (2004) 1.03
Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res (2010) 1.02
Delorme's procedure revisited for an incarcerated transverse loop colostomy prolapse repair. Am Surg (2013) 1.00
Contraindications of sentinel lymph node biopsy: are there any really? World J Surg Oncol (2007) 1.00
Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg (2009) 0.99
Reinforcing the staple line during laparoscopic sleeve gastrectomy: prospective randomized clinical study comparing two different techniques. Preliminary results. Obes Surg (2012) 0.99
Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer. Expert Rev Anticancer Ther (2006) 0.99
Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism (2011) 0.95
Association of aberrant DNA methylation with clinicopathological features in breast cancer. Oncol Rep (2011) 0.92
Morbid obesity and sleeve gastrectomy: how does it work? Obes Surg (2010) 0.92
C-reactive protein, white blood cells, and neutrophils as early predictors of postoperative complications in patients undergoing laparoscopic sleeve gastrectomy. Surg Endosc (2012) 0.91
Clinical implications of sleeve gastrectomy as a source of spleen infarction or ischemia. Obes Surg (2011) 0.91
Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn (2010) 0.90
Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep (2013) 0.90
Routine abdominal drains after laparoscopic sleeve gastrectomy: a retrospective review of 353 patients. Obes Surg (2011) 0.89
Long-term plasma ghrelin and leptin modulation after sleeve gastrectomy in Wistar rats in comparison with gastric tissue ghrelin expression. Obes Surg (2011) 0.89
Pancreatic leak related hemorrhage following pancreaticoduodenectomy. A case series. JOP (2009) 0.88
Breast cancer nodal metastasis correlates with tumour and lymph node methylation profiles of Caveolin-1 and CXCR4. Clin Exp Metastasis (2014) 0.88
Coexistence of tumor-induced osteomalacia and primary hyperparathyroidism. Endocr Pract (2011) 0.87
Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer? Surg Endosc (2008) 0.87
Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther (2009) 0.86
Postoperative pulmonary function after open abdominal aortic aneurysm repair in patients with chronic obstructive pulmonary disease: epidural versus intravenous analgesia. Ann Vasc Surg (2011) 0.86
Is early laparoscopic cholecystectomy for acute cholecystitis preferable to delayed surgery?: Best evidence topic (BET). Int J Surg (2012) 0.86
Esophageal Doppler (ODM II) improves intraoperative hemodynamic monitoring during laparoscopic surgery. Surg Laparosc Endosc Percutan Tech (2005) 0.86
Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression. Anticancer Res (2014) 0.86
Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol (2008) 0.85
Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension. J Clin Endocrinol Metab (2013) 0.85
Localized peripancreatic plasma cell Castleman disease. Am J Surg (2010) 0.84
Do anastomotic leaks impair postoperative health-related quality of life after rectal cancer surgery? A case-matched study. Dis Colon Rectum (2014) 0.84
Intestinal preconditioning ameliorates ischemia-reperfusion induced acute lung injury in rats: an experimental study. J Surg Res (2009) 0.83
Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology. World J Gastroenterol (2012) 0.83
Genomics and challenges toward personalized breast cancer local control. J Clin Oncol (2008) 0.82
Current advantages in the application of proteomics in inflammatory bowel disease. Dig Dis Sci (2012) 0.82
Prospective comparative study of the efficacy of staple-line reinforcement in laparoscopic sleeve gastrectomy. Surg Endosc (2011) 0.82
Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer. Anticancer Res (2008) 0.82
Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system. J Surg Res (2009) 0.81
Laparoscopic colectomy in the management of large, sessile, transformed colorectal polyps. JSLS (2005) 0.81
High ligation of inferior mesenteric artery: a standard procedure for colorectal cancer? Ann Surg Oncol (2011) 0.81
Synchronous bilateral breast cancer with different biological profile and estrogen-progesterone receptor status. Breast J (2008) 0.80
Short bowel syndrome: current medical and surgical trends. J Clin Gastroenterol (2007) 0.80
Submucosal anoderm-preserving hemorrhoidectomy revisited: a modified technique for the surgical management of hemorrhoidal crisis. Am Surg (2013) 0.80
Effects of mycophenolate mofetil vs cyclosporine administration on graft survival and function after islet allotransplantation in diabetic rats. World J Gastroenterol (2005) 0.79
Alternations of 14-3-3 θ and β protein levels in brain during experimental sepsis. J Neurosci Res (2011) 0.78
Endoscopic ultrasound staging and guided fine needle aspiration biopsy in patients with resectable pancreatic malignancies: a single-center prospective experience. Onkologie (2011) 0.78
A pleomorphic rhabdomyosarcoma mimicking an inguinal hernia: a case report and review of the literature. Case Rep Oncol (2012) 0.78
Decreased Hsp90 expression in infiltrative lobular carcinoma: an immunohistochemical study. BMC Cancer (2010) 0.77
EGFR as a Prognostic Marker for Gastric Cancer. World J Surg (2008) 0.77
Gastroesophageal junction carcinoma multimodal treatment: standards, debate and new therapeutic options. Expert Rev Gastroenterol Hepatol (2011) 0.77
Incidence, risk factors, and outcome of portal vein thrombosis after laparoscopic-assisted splenectomy in β-thalassemia patients: a prospective exploratory study. J Laparoendosc Adv Surg Tech A (2013) 0.77
Translating cancer genomes sequencing revolution into surgical oncology practice. J Surg Res (2010) 0.77
The Acute Effect of the Antioxidant Drug U-74389G on Red Blood Cell Distribution Width Levels During Hypoxia Reoxygenation Injury in Rats. Folia Med (Plovdiv) (2016) 0.77
Postoperative cardiac damage after standardized carotid endarterectomy procedures in low- and high-risk patients. Ann Vasc Surg (2013) 0.77
Complete endoscopic axillary lymph node dissection without liposuction for breast cancer: initial experience and mid-term outcome. Surg Laparosc Endosc Percutan Tech (2006) 0.76
Everolimus and sunitinib: from mouse models to treatment of pancreatic neuroendocrine tumors. Future Oncol (2011) 0.76
Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma. A phase III randomized study. Chemotherapy (2007) 0.76
Deep sequencing and integrative genome analysis: approaching a new class of biomarkers and therapeutic targets for breast cancer. Pharmacogenomics (2013) 0.76
Novel next-generation sequencing and networks-based therapeutic targets: realistic and more effective drug design and discovery. Curr Pharm Des (2014) 0.76
Cytoreductive surgery and HIPEC for peritoneal carcinomatosis. A review on morbidity and mortality. J BUON (2015) 0.76
Amifostine, in a reduced dose, protects against severe diarrhea associated with weekly fluorouracil and folinic acid chemotherapy in advanced colorectal cancer: a pilot study. J Pain Symptom Manage (2003) 0.75
Lesions of "uncertain malignant potential" diagnosed by vacuum-assisted breast biopsy: an unclear management? Ann Surg Oncol (2008) 0.75
Changes in T-lymphocytes' viability after laparoscopic versus open cholecystectomy. Int Surg (2015) 0.75
Benefits and harms in avoiding axilla lymphadenectomy in breast cancer. Ann Surg Oncol (2008) 0.75
Minimally invasive esophagectomy. Surg Endosc (2010) 0.75
Local control, aggressive surgery, and overall survival for breast cancer. Ann Surg Oncol (2008) 0.75
Combined general-epidural anesthesia with continuous postoperative epidural analgesia preserves sigmoid colon perfusion in elective infrarenal aortic aneurysm repair. Saudi J Anaesth (2013) 0.75
Screening for or prevention of local ipsilateral recurrence and contralateral breast cancer after breast-conserving surgery? Ann Surg Oncol (2008) 0.75
Does lymphadenectomy improve survival of patients with solid tumors? Ann Surg Oncol (2007) 0.75
Reducing local recurrence after breast-conserving surgery for breast cancer. Ann Surg Oncol (2007) 0.75
Can VEGF-D and VEGFR-3 be used as biomarkers for therapeutic decisions in patients with gastric cancer? Nat Clin Pract Oncol (2006) 0.75
Major depression in elderly medical inpatients in Greece, prevalence and identification. Aging Clin Exp Res (2010) 0.75
Esophagus and Gastric Cancer: How Surgeon's Experience and Personal Genomics May Improve Locoregional Control and Survival. World J Surg (2009) 0.75
Challenges in the treatment of gastroesophageal junction cancer. World J Surg (2011) 0.75
Totally laparoscopic total gastrectomy and the challenge of esophagojejunostomy. Surg Endosc (2011) 0.75
Thoracolaparoscopic esophagectomy: further improvement in the multimodal treatment of esophageal cancer. Surg Endosc (2011) 0.75
Breast-conserving surgery in Asian women: benefits and potential harm. World J Surg (2009) 0.75
Early signet ring cell or diffuse-type gastric cancer: risks for endoscopic mucosal resection. Ann Surg Oncol (2008) 0.75
The use of serum uric Acid concentration as an indicator of laparoscopic sleeve gastrectomy success. Int Surg (2015) 0.75
Expectations and challenges of laparoscopic total gastrectomy. Surg Endosc (2009) 0.75
Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension. J Clin Endocrinol Metab (2012) 0.75
Dermal flap advancement combined with conservative sphincterotomy in the treatment of chronic anal fissure. Am Surg (2015) 0.75
Male breast cancer originating in an ectopic breast tissue in the umbilicus A Case Report. Ann Ital Chir (2016) 0.75
Peritoneal recurrence for gastric cancer: can it be prevented? Ann Surg Oncol (2007) 0.75
Intensive care unit hospitalization after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J BUON (2016) 0.75
Locoregional treatment of peritoneal sarcomatosis A single-centre experience. Ann Ital Chir (2016) 0.75
Serum VEGF and bFGF in patients with inflammatory bowel diseases. Ann Ital Chir (2014) 0.75
Delayed tracheal rupture after thyroidectomy. Am Surg (2012) 0.75
Efficacy of incisional infiltration and intraperitoneal instillation of ropivacaine for the management of pain after laparoscopic sleeve gastrectomy: A randomised clinical trial. Eur J Anaesthesiol (2020) 0.75